Antitrust in Pharmaceuticals: A New Chapter with Ross Elfand at King & Spalding
Strategic Hiring for Antitrust Work
King & Spalding has taken a significant step by hiring acclaimed antitrust litigator Ross Elfand from White & Case. The firm underscores that this addition is not merely an expansion but a necessary response to the growing complexities in antitrust law related to the pharmaceutical sector.
Meeting Demand in the Pharmaceutical Sector
With increasing scrutiny on antitrust issues affecting pharmaceuticals, Ross Elfand’s experience will play a critical role.
- Addressing legal challenges in mergers and acquisitions
- Enhancing litigation capabilities for clients in the healthcare industry
- Providing strategic guidance on compliance and regulatory matters
As the pharmaceutical industry continues to evolve, King & Spalding is poised to lead the way in antitrust advocacy.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.